Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing / G.A. Lanza, K. Fox, and F. Crea -- If current inhibition: cellular basis and physiology / M.E. Mangoni, L. Marger, and J. Nargeot -- Heart rate reduction by pharmacological If current inhibition / A. Cargnoni ... [et al.] -- Clinical perspectives of heart rate slowing for coronary event reduction and heart failure / N. Danchin and Z. Kadri -- Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradine / J.S. Borer -- Heart rate slowing versus other pharmacological antianginal strategies. Results of comparative studies / A. Diaz and J.-C. Tardif -- Novel If current inhibitor ivabradine: safety considerations / I. Savelieva and A.J. Camm -- Heart rate slowing for myocardial dysfunction/heart failure. Rationale and preclinical studies / P. Mulder and C. Thuillez -- Future directions: what data do we need? / M. Tendera.